Inventor

MALDONADO ROBERTO A

US21 patents

⚠️ This page may combine multiple inventors who share the name “MALDONADO ROBERTO A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MALDONADO ROBERTO A

SELECTA BIOSCIENCES INC

Tolerogenic synthetic nanocarriers for inducing regulatory B cells

Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen

Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells

Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose

Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells

Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity

Methods comprising dosing combinations for reducing undesired humoral immune responses

Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses

Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses

Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity

Tolerogenic synthetic nanocarriers for allergy therapy

Tolerogenic synthetic nanocarriers

FRASER CHRISTOPHER

Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells

Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins

Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses

Tolerogenic synthetic nanocarriers

KISHIMOTO TAKASHI KEI

Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells

Tolerogenic synthetic nanocarriers for allergy therapy

CARTESIAN THERAPEUTICS INC

Methods related to administering immunosuppressants and non-allergenic antigens to reduce or prevent anaphylaxis

Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both Type 1 and Type IV hypersensitivity

MALDONADO ROBERTO A

Tolerogenic synthetic nanocarriers for inducing regulatory B cells